
Creative Commons Zero, Public Domain Dedication
Has participated in:
-
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
-
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
-
Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective
-
Effect of reconstituted human apolipoprotein A-I on recurrent ischemic events in survivors of acute MI